Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Lowered by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 921 shares of the medical equipment provider’s stock after selling 573 shares during the quarter. Verdence Capital Advisors LLC’s holdings in Intuitive Surgical were worth $481,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management lifted its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 492 shares of the firm’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $554.17, for a total transaction of $272,651.64. Following the completion of the transaction, the senior vice president now directly owns 3,072 shares of the company’s stock, valued at $1,702,410.24. This represents a 13.80 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,090 shares of company stock worth $7,496,119. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $538.57 on Friday. The firm has a market cap of $191.83 billion, a price-to-earnings ratio of 84.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm’s 50 day moving average price is $571.70 and its two-hundred day moving average price is $530.95.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ISRG. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Truist Financial lifted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.